Molecular engineering of ionic organic phototheranostic agents for NIR-II imaging-guided synergistic phototherapy

Abstract

We develop ionic small-molecule phototheranostics by molecular engineering of positive charges and hydrophilicity/hydrophobicity balance. The optimized agent, 2PyI, achieves balanced amphiphilicity, enabling efficient NIR-II emission, reactive oxygen species generation, and photothermal conversion. It facilitates high-resolution NIR-II imaging-guided synergistic photodynamic/photothermal therapy.

Graphical abstract: Molecular engineering of ionic organic phototheranostic agents for NIR-II imaging-guided synergistic phototherapy

Supplementary files

Article information

Article type
Communication
Submitted
16 Jan 2026
Accepted
11 Feb 2026
First published
12 Feb 2026

Chem. Commun., 2026, Advance Article

Molecular engineering of ionic organic phototheranostic agents for NIR-II imaging-guided synergistic phototherapy

J. Gong, Y. Zhang, C. Lu, G. Jiang, Q. Jin and J. Wang, Chem. Commun., 2026, Advance Article , DOI: 10.1039/D6CC00306K

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements